Educational Intervention for Reducing Work Disability in Breast Cancer Survivors



Status:Active, not recruiting
Conditions:Breast Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:25 - 64
Updated:6/16/2016
Start Date:July 2015
End Date:October 2017

Use our guide to learn which trials are right for you!

Reducing Work Disability in Breast Cancer Survivors

This randomized clinical trial studies an educational intervention for reducing work
disability in breast cancer survivors. Web sites providing symptom management education may
be an effective method to help breast cancer survivors reduce work disability after
treatment

PRIMARY OBJECTIVES:

I. Determine the feasibility and usability of the Work Ability Improvement Through Symptom
Management and Ergonomic Strategies (WISE) and empirically evaluate its effect on short-term
work ability among breast cancer survivors (BCS).

SECONDARY OBJECTIVES:

I. Explore individual and workplace factors associated with work ability in BCS.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients receive access to the WISE web-based educational intervention to help BCS
manage their symptoms, identify ergonomic workplace problems and risks, and implement
ergonomic modifications. Patients also receive standard of care comprising symptom
management therapies and a pamphlet on employment rights.

ARM II: Patients receive standard of care comprising symptom management therapies and a
pamphlet on employment rights.

After completion of study treatment, patients are followed up at 3 and 6 months.

Inclusion Criteria:

- Diagnosed with breast cancer

- Employed at time of cancer diagnosis (defined as paid employment > 20 hours/week)

- Within six months of completion of active treatment

- Working during treatment or intending to return to work following active treatment

- Computer and internet access

Exclusion Criteria:

- Patients who do not intend to continue/resume working following treatment

- Develop distant metastases or progressive disease

- Prior diagnosis of malignancy at any other site except for in situ carcinomas of the
cervix or non-melanomatous skin cancers
We found this trial at
1
site
600 Highland Ave
Madison, Wisconsin 53792
(608) 263-6400
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
?
mi
from
Madison, WI
Click here to add this to my saved trials